Delivery Order SPE2DB20D1100-SPE2DB25FE3B9
- Not listed
- The Defense Logistics Agency awarded a $32,329.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with a completion date of August 7, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $13,297.03 to AmerisourceBergen Drug Corp for supply of Biktarvy 50-200-25 mg tablets (30-count units) with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at approximately $72.8K to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed-price contract with an ultimate completion date of November 7, 2025. This non-set-aside award represents a competitive procurement of pharmaceutical products to support federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $86,231.50 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, issued on July 24, 2025, with completion scheduled for July 25, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,064.27 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of October 29, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at approximately $165,000 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $24,069.09 firm fixed price delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with a completion date of September 30, 2025. This non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $34.5K delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-unit packages. This non-set-aside, firm fixed-price contract represents a delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a delivery order valued at $108,860.15 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3B9Delivery Order
The Defense Logistics Agency awarded a $66,030.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The underlying contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.0k | 8/27/25 |